Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature
European Journal of Neurology · 2023-06 · 30 (6) · 1801-1814
DOI: 10.1111/ene.15758 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Neurology, online erschienen am 20.03.2023. Verfasst von Alejandro León Betancourt und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Encephalitis, Cerebellar Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and purpose Kelchlike protein 11 antibodies (KLHL11‐IgGs) were first described in 2019 as a marker of paraneoplastic neurological syndromes (PNSs). They have mostly been associated with testicular germ cell tumors (tGCTs).
Methods
Two patients with KLHL11‐IgG encephalitis are reported, and the literature is comprehensively reviewed.
Results
Patient 1 had been in remission from a tGCT 10 years prior. He developed episodic vertigo and diplopia progressing over a few days. Treatment with corticosteroids (CSs) was started a few days after symptom onset. Patient 2 had transient diplopia, which resolved spontaneously. Visual problems persisted for 7 months, when he additionally developed a progressive cerebellar syndrome. One year after onset, CS treatment was started. Initial magnetic resonance imaging was unremarkable in both patients, but analysis of cerebrospinal fluid (CSF) revealed chronic inflammation. KLHL11‐IgG was positive in both patients (Patient 1 only in CSF, Patient 2 in serum). Neoplastic screening has so far not revealed any signs of active underlying malignancy. We found 15 publications of 112 patients in total with KLHL11‐IgG encephalitis. Most patients ( n = 82) had a cerebellar syndrome with or without signs of rhombencephalitis. The most common symptoms were ataxia ( n = 82) and vertigo ( n = 47), followed by oculomotor disturbances ( n = 35) and hearing disorders ( n = 31). Eighty of 84 patients had a GCT as an underlying tumor.
Conclusions
Our cases demonstrate classical symptoms of KLHL11‐IgG encephalitis. Early diagnosis and therapy are imperative. As with other PNSs, clinical awareness is needed and further studies are required especially in regard to therapeutic management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
- Neuroimmunology Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Fundació Clínic per a la Recerca Biomèdica, University Hospital Barcelona, Barcelona, Spain.
ORCID-Profile: Alejandro León Betancourt, Robert Hoepner, Anke Salmen
Zitieren
APA
León Betancourt, A., Schwarzwald, A., Millonig, A., Oberholzer, M., Sabater, L., Hammer, H., Kamber, N., Diem, L., Chan, A., Hoepner, R., Salmen, A., & Friedli, C. (2023). Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature. European Journal of Neurology, 30(6), 1801-1814. https://doi.org/10.1111/ene.15758
Vancouver
León Betancourt A, Schwarzwald A, Millonig A, Oberholzer M, Sabater L, Hammer H, et al. Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature. European Journal of Neurology. 2023;30(6):1801-1814. doi:10.1111/ene.15758
BibTeX
@article{LenBetancourt2023,
author = {León Betancourt, Alejandro and Schwarzwald, Anina and Millonig, Alban and Oberholzer, Michael and Sabater, Lidia and Hammer, Helly and Kamber, Nicole and Diem, Lara and Chan, Andrew and Hoepner, Robert and Salmen, Anke and Friedli, Christoph},
title = {Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature},
journal = {European Journal of Neurology},
year = {2023},
volume = {30},
number = {6},
pages = {1801--1814},
doi = {10.1111/ene.15758}
}
EUVIMED